JPS5289660A - Blood lipid lowering paraaaminobenzoic acids - Google Patents

Blood lipid lowering paraaaminobenzoic acids

Info

Publication number
JPS5289660A
JPS5289660A JP384477A JP384477A JPS5289660A JP S5289660 A JPS5289660 A JP S5289660A JP 384477 A JP384477 A JP 384477A JP 384477 A JP384477 A JP 384477A JP S5289660 A JPS5289660 A JP S5289660A
Authority
JP
Japan
Prior art keywords
paraaaminobenzoic
acids
blood lipid
lipid lowering
lowering
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP384477A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6233230B2 (en:Method
Inventor
Rosu Wagunaa Yuujiin
Jiyueru Aren Bobii
Aasaa Renji Arufuretsudo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dow Chemical Co
Original Assignee
Dow Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Chemical Co filed Critical Dow Chemical Co
Publication of JPS5289660A publication Critical patent/JPS5289660A/ja
Publication of JPS6233230B2 publication Critical patent/JPS6233230B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58—Radicals substituted by nitrogen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
JP384477A 1976-01-19 1977-01-17 Blood lipid lowering paraaaminobenzoic acids Granted JPS5289660A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US65009076A 1976-01-19 1976-01-19

Publications (2)

Publication Number Publication Date
JPS5289660A true JPS5289660A (en) 1977-07-27
JPS6233230B2 JPS6233230B2 (en:Method) 1987-07-20

Family

ID=24607411

Family Applications (1)

Application Number Title Priority Date Filing Date
JP384477A Granted JPS5289660A (en) 1976-01-19 1977-01-17 Blood lipid lowering paraaaminobenzoic acids

Country Status (14)

Country Link
JP (1) JPS5289660A (en:Method)
AT (1) AT347923B (en:Method)
AU (1) AU500881B2 (en:Method)
BE (1) BE850516A (en:Method)
CA (1) CA1072969A (en:Method)
CH (1) CH628340A5 (en:Method)
DE (1) DE2702058C2 (en:Method)
DK (1) DK153471C (en:Method)
FR (1) FR2338040A1 (en:Method)
GB (2) GB1521458A (en:Method)
IE (1) IE44858B1 (en:Method)
NL (1) NL7700480A (en:Method)
NO (1) NO145839C (en:Method)
SE (1) SE435175B (en:Method)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE716668C (de) * 1938-02-15 1942-01-27 Dr Aladar Skita Verfahren zur Herstellung von Derivaten substituierter Aminobenzoesaeuren
FR2080069A5 (en:Method) * 1970-02-23 1971-11-12 Commissariat Energie Atomique
US3868416A (en) * 1973-10-01 1975-02-25 American Cyanamid Co Hypolipidemic 4-(monoalkylamino)benzoic acid derivatives

Also Published As

Publication number Publication date
GB1521459A (en) 1978-08-16
BE850516A (fr) 1977-07-19
DK153471B (da) 1988-07-18
NL7700480A (nl) 1977-07-21
NO770151L (no) 1977-07-20
IE44858L (en) 1977-07-19
AU500881B2 (en) 1979-06-07
NO145839C (no) 1982-06-09
FR2338040B1 (en:Method) 1980-04-30
DE2702058A1 (de) 1977-07-28
IE44858B1 (en) 1982-04-21
GB1521458A (en) 1978-08-16
AU2114077A (en) 1978-07-13
DK8177A (da) 1977-07-20
SE7700490L (sv) 1977-07-20
AT347923B (de) 1979-01-25
FR2338040A1 (fr) 1977-08-12
SE435175B (sv) 1984-09-10
CH628340A5 (en) 1982-02-26
ATA31277A (de) 1978-06-15
NO145839B (no) 1982-03-01
CA1072969A (en) 1980-03-04
JPS6233230B2 (en:Method) 1987-07-20
DK153471C (da) 1988-11-21
DE2702058C2 (de) 1985-09-19

Similar Documents

Publication Publication Date Title
ZA77564B (en) Carboxyalkylacylamino acids
JPS52135599A (en) Blood glucose controller
JPS5298380A (en) Catheter
ZA771575B (en) Catheter support
JPS5488291A (en) Substituteddpenn22mmcarboxylic acids
NZ186679A (en) 7-substituted-3-cephem-4-carboxylic acids
JPS5320688A (en) Catheter
JPS5286294A (en) Blood pump
AU3337678A (en) Benzoic acids
JPS5369488A (en) Catheter
ZA773055B (en) 12-azaprostanoic acids
GR63666B (en) Trans-hexahydro-pyrido-indole-2-alkanols,-alkanones,-alkanonitriles-alkanoic acids 8 esters
CA1109861A (en) 2-methylpenem-3-carboxylic acids
JPS52118671A (en) Blood cleaner
NZ187534A (en) Ethynyl - aminoacetic acids
NZ187377A (en) A-amino-a-substituted alkyl-a-fluoromethylacetic acids
AU2985577A (en) N-chloroacetyl-n-phenyl-alanine esters
ZA777629B (en) Sulphamoylbenzoic acids
JPS52258A (en) Blood lipid lowering agent
JPS5342491A (en) Blood dialyzer
ZA781127B (en) 1-azaxanthone-3-carboxylic acids
JPS5318543A (en) Cyclopropyllmethyllphosphoric acid derivative
ZA775350B (en) Substituted 5-amino-2-pyridinecarboxylic acids
AU2855777A (en) Benzoic acids
JPS5318296A (en) Blood processor